• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    RenovoRx, Inc. - Common Stock (NQ:RNXT)

    1.050 +0.020 (+1.94%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 14, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 223,052
    Open 1.080
    Bid (Size) 1.010 (35)
    Ask (Size) 1.070 (49)
    Prev. Close 1.030
    Today's Range 1.035 - 1.080
    52wk Range 0.7500 - 1.690
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Earnings Preview For RenovoRx
    Via Benzinga
    RenovoRx to Participate in Fireside Chat at A.G.P. Virtual Healthcare Company Showcase on May 21st
    From RenovoRx, Inc.
    Via Business Wire

    Performance

    YTD
    -22.8%
    -22.8%
    1 Month
    +24.3%
    +24.3%
    3 Month
    -9.5%
    -9.5%
    6 Month
    -3.7%
    -3.7%
    1 Year
    -27.6%
    -27.6%

    More News

    Read More
    U.S. Patent Office Issues New Patent to RenovoRx for Novel Trans-Arterial Micro-Profusion (TAMP™) Therapy Platform
    From RenovoRx, Inc.
    Via Business Wire
    RenovoRx to Host First Quarter 2025 Financial Results Conference Call on May 15th at 4:30 p.m. ET
    From RenovoRx, Inc.
    Via Business Wire
    Johns Hopkins Medicine Initiates Patient Enrollment for RenovoRx’s Ongoing Phase III TIGeR-PaC Clinical Trial
    From RenovoRx, Inc.
    Via Business Wire
    RenovoRx Increases U.S. Production of RenovoCath® Devices to Meet Growing Demand from Oncology Community
    From RenovoRx, Inc.
    Via Business Wire
    These stocks are moving in today's pre-market session
    Via Chartmill
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    RenovoRx to Present at LD Micro Invitational XV Conference in New York on April 10th
    From RenovoRx, Inc.
    Via Business Wire
    RenovoRx Reports Initial Revenues from RenovoCath® Commercialization, and Provides Update on Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
    From RenovoRx, Inc.
    Via Business Wire
    RenovoRx Highlights New Human Pharmacokinetic Data Abstract at SSO 2025 Annual Meeting
    From RenovoRx, Inc.
    Via Business Wire
    RenovoRx Pre-Clinical Results Supporting TAMP™ as a Targeted Locoregional Drug Delivery Platform to Receive Award at SIR 2025 Annual Scientific Meeting
    From RenovoRx, Inc.
    Via Business Wire
    RenovoRx CEO to Provide Strategic Update During Fireside Chat on Thursday, April 3rd at 12:00 p.m. ET
    From RenovoRx, Inc.
    Via Business Wire
    RenovoRx Announces Abstract Presentation at the Society of Surgical Oncology (SSO) 2025
    From RenovoRx, Inc.
    Via Business Wire
    RenovoRx Advances Commercialization of RenovoCath® with Several New Purchase Orders, Including Customer Reorders
    From RenovoRx, Inc.
    Via Business Wire
    RenovoRx Highlights Promising Pre-Clinical Data Abstract: TAMP™ Therapy Platform Offers Potential to Improve Localized and Targeted Drug Delivery
    From RenovoRx, Inc
    Via Business Wire
    BioMedNewsBreaks – RenovoRx Inc. (NASDAQ: RNXT) Announces $12.1M Underwritten Public Offering
    Via Investor Brand Network
    Exposures Product Safety
    RenovoRx Announces Closing of $12.1 Million Underwritten Public Offering of Common Stock
    From RenovoRx, Inc.
    Via Business Wire
    What's going on in today's pre-market session
    Via Chartmill
    RenovoRx Announces Pricing of $12.1 Million Underwritten Public Offering of Common Stock
    From RenovoRx, Inc.
    Via Business Wire
    These stocks are moving in today's after hours session
    Via Chartmill
    RenovoRx Announces Proposed Public Offering
    From RenovoRx, Inc.
    Via Business Wire
    RenovoRx Highlights Promising Pharmacokinetic Data Abstract Presented at ASCO GI 2025
    From RenovoRx, Inc.
    Via Business Wire
    RenovoRx Announces Acceptance of Abstract for Presentation at ASCO Gastrointestinal Cancers Symposium 2025
    From RenovoRx, Inc.
    Via Business Wire
    RenovoRx Continues to Grow Intellectual Property Portfolio for its Novel Drug-Delivery Therapy Platform
    From RenovoRx, Inc.
    Via Business Wire

    Frequently Asked Questions

    Is RenovoRx, Inc. - Common Stock publicly traded?
    Yes, RenovoRx, Inc. - Common Stock is publicly traded.
    What exchange does RenovoRx, Inc. - Common Stock trade on?
    RenovoRx, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for RenovoRx, Inc. - Common Stock?
    The ticker symbol for RenovoRx, Inc. - Common Stock is RNXT on the Nasdaq Stock Market
    What is the current price of RenovoRx, Inc. - Common Stock?
    The current price of RenovoRx, Inc. - Common Stock is 1.050
    When was RenovoRx, Inc. - Common Stock last traded?
    The last trade of RenovoRx, Inc. - Common Stock was at 05/14/25 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.